Intubation and mechanical ventilation of patients with COVID-19: what should we tell them?

Abstract

Severe COVID-19 illness is characterised by the development of Acute Respiratory Distress Syndrome (ARDS), for which the mainstay of treatment is represented by mechanical ventilation. Mortality associated with ARDS due to other causes is in the range of 40-60%, but currently available data are not yet sufficient to draw safe conclusions on the prognosis of COVID-19 patients who require mechanical ventilation. Based on data from cohorts of the related coronavirus-associated illnesses, that is to say Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS), prognosis would seem to be worse than ARDS due to other causes such as trauma and other infections. Discussion of prognosis is central to obtaining informed consent for intubation, but in the absence of definitive data it is not clear exactly what this discussion should entail.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2020-04-08
Info
Issue
Section
COVID-19 - Collection of articles on the Coronavirus outbreak
Keywords:
COVID-19, SARS-CoV-2, critical care, mechanical ventilation, intubation
Statistics
  • Abstract views: 3012

  • PDF: 1842
How to Cite
Zareifopoulos, N., Lagadinou, M., Karela, A., Karantzogiannis, G., & Velissaris, D. (2020). Intubation and mechanical ventilation of patients with COVID-19: what should we tell them?. Monaldi Archives for Chest Disease, 90(1). https://doi.org/10.4081/monaldi.2020.1296

Most read articles by the same author(s)